Sign inGet started

Rodriguez Susan

Insider CIK 1812511 · AVDL Chief Operating Officer · MDRX Director · ARDX Chief Commercial Officer · MNPR CCSO · HRTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MDRX Veradigm Inc. A Award2026-06-012026-06-0342,507— $0131,125SEC↗
MNPR Monopar Therapeutics A Award deriv2026-03-022026-03-0448,728— $048,728SEC↗
AVDL AVADEL PHARMACEUTICALS PLC D To issuer deriv2026-02-122026-02-12300,000— $00SEC↗
MDRX Veradigm Inc. A Award2025-06-022025-06-0346,512$4.30 $200.0K88,618SEC↗
AVDL AVADEL PHARMACEUTICALS PLC A Award deriv2025-05-132025-05-13300,000— $0300,000SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award deriv2025-01-312025-02-0435,900— $035,900SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award2025-01-312025-02-0417,950— $087,180SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award deriv2025-01-302025-02-0335,900$1.73 $62.1K35,900SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award2025-01-302025-02-0317,950— $087,180SEC↗
MDRX Veradigm Inc. A Award2024-05-312024-06-2042,106— $042,106SEC↗
ARDX ARDELYX, INC. S Sale2024-05-212024-05-236,703$7.81 $52.4K449,092SEC↗
ARDX ARDELYX, INC. S Sale2024-02-202024-02-226,928$8.75 $60.6K452,795SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award deriv2024-01-192024-01-1983,685— $083,685SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award2024-01-192024-01-1913,948— $069,230SEC↗
ARDX ARDELYX, INC. A Award deriv2024-01-162024-01-18145,000— $0145,000SEC↗
ARDX ARDELYX, INC. A Award2024-01-162024-01-18112,750— $0459,723SEC↗
ARDX ARDELYX, INC. S Sale2023-11-202023-11-224,714$4.36 $20.6K346,973SEC↗
ARDX ARDELYX, INC. S Sale2023-08-212023-08-234,733$3.55 $16.8K348,687SEC↗
ARDX ARDELYX, INC. S Sale2023-05-232023-05-254,711$3.65 $17.2K353,420SEC↗
ARDX ARDELYX, INC. S Sale2023-02-212023-03-025,586$3.00 $16.8K355,131SEC↗
ARDX ARDELYX, INC. A Award deriv2023-01-052023-01-06351,000— $0351,000SEC↗
ARDX ARDELYX, INC. A Award2023-01-052023-01-0678,000— $0360,717SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award deriv2022-12-162022-12-2077,160— $077,160SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award2022-12-162022-12-2038,580— $055,282SEC↗
ARDX ARDELYX, INC. S Sale2022-11-222022-11-23131$1.94 $254286,042SEC↗
ARDX ARDELYX, INC. S Sale2022-11-222022-11-233,303$1.95 $6.4K282,717SEC↗
ARDX ARDELYX, INC. S Sale2022-11-222022-11-2322$1.95 $43286,020SEC↗
ARDX ARDELYX, INC. S Sale2022-08-222022-08-243,356$0.98 $3.3K286,237SEC↗
ARDX ARDELYX, INC. S Sale2022-08-222022-08-2464$0.98 $63286,173SEC↗
ARDX ARDELYX, INC. S Sale2022-06-062022-06-08910$0.64 $582289,593SEC↗
ARDX ARDELYX, INC. S Sale2022-06-062022-06-0843,010$0.65 $28.0K290,503SEC↗
ARDX ARDELYX, INC. S Sale2022-05-202022-05-233,425$0.67 $2.3K333,513SEC↗
ARDX ARDELYX, INC. S Sale2022-02-222022-02-253,400$0.67 $2.3K333,938SEC↗
ARDX ARDELYX, INC. A Award deriv2022-01-062022-01-12195,000— $0195,000SEC↗
ARDX ARDELYX, INC. A Award2022-01-062022-01-12141,000— $0338,031SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award deriv2021-12-222021-12-2320,903— $020,903SEC↗
HRTX HERON THERAPEUTICS, INC. / A Award2021-12-222021-12-2310,452— $016,702SEC↗
ARDX ARDELYX, INC. S Sale2021-11-222021-11-24643$0.99 $637197,030SEC↗
ARDX ARDELYX, INC. A Award2021-10-082021-10-29150,000— $0197,673SEC↗
ARDX ARDELYX, INC. S Sale2021-08-202021-08-24630$1.32 $83244,673SEC↗
ARDX ARDELYX, INC. S Sale2021-05-202021-05-21611$7.09 $4.3K45,303SEC↗
ARDX ARDELYX, INC. S Sale2021-02-222021-02-24611$6.88 $4.2K45,914SEC↗
ARDX ARDELYX, INC. A Award deriv2021-01-052021-01-07146,755— $0146,755SEC↗
ARDX ARDELYX, INC. A Award2021-01-052021-01-0732,612— $046,525SEC↗
ARDX ARDELYX, INC. S Sale2020-09-162020-09-176,087$6.11 $37.2K13,913SEC↗
ARDX ARDELYX, INC. A Award deriv2020-05-182020-05-20232,750— $0232,750SEC↗
ARDX ARDELYX, INC. A Award2020-05-182020-05-2020,000— $020,000SEC↗